Fact CheckerSign in

NCT06957340Completed

Observation on the Therapeutic Effect of Low-Intensity Transcranial Ultrasound Stimulation Combined With Upper Limb Virtual Reality Training on Post-Stroke Depression

Source: ClinicalTrials.gov · Last updated 4 May 2025

Brief summary (registry, in English)

Abstract: objective:To study whether post-stroke depression can be improved through low-intensity transcranial ultrasound stimulation combined with upper limb virtual reality training, explore its possible mechanisms, and provide new rehabilitation strategies for further treatment of post-stroke depression patients. Methods:30 patients with PSD were selected as the subjects, and randomly divided into sham control group and combination treatment group according to computer randomization. Each group was 15 cases. The combined treatment group was subjected to LITUS, virtual reality upper limb training, routine medication and rehabilitation treatment. The control group only conducted virtual upper limb training, routine medication and rehabilitation treatment, and TUS was a false stimulation treatment. Keywords:Ultrasoun,transcranial,ultrasound,stimulation,virtual reality,stroke,post-stroke depression

Status (registry)
Completed
Study type
Interventional
Enrollment
30 (actual)
First submitted
19 Apr 2025
Start date
1 Jan 2023
Primary completion date
31 Oct 2024
Lead sponsor
Anhui Medical University
Diseases
Stroke
NCT number
NCT06957340

What you commit to

  • Study type: Interventional
  • Participants enrolled: 30
  • From 1 Jan 2023 to the primary completion date, 31 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • The exclusion criteria were as follows:
    • Patients with metallic implants in the cranium or those with a pacemaker;
    • Patients with unstable conditions, multiple brain infarctions, severe heart disease, or other significant organ conditions and complications, or a history of cancer.

Who the study is looking for

  • The inclusion criteria were as follows:
    • First-time stroke patients diagnosed with ischemic stroke via imaging techniques such as CT or MRI;
    • Duration of the disease between 15 days and 6 months, with stable condition;Age between 18 and 75 years;
    • Patients without severe intellectual, language comprehension, or behavioral impairments, capable of completing scale assessments, with an MMSE score of ≥24;
    • Hemiplegia on one side and at least a 3rd-level seated balance, with Brunnstrom stage II or higher for the upper limb,able to perform movements with the assistance of the upper limb virtual reality training;
    • No use of antidepressant medications in the past month, with PHQ-9 score≥10 and HAMA score≥17;
    • Patients who are aware of the study details and have signed the informed consent form.

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Anhui Medical University
Coordinator of this site? Confirm its status
HefeiChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.